


Southwest Ohio Ketamine TMS and IV Therapy operates in Dayton, OH, as a specialized clinic focusing on treatment-resistant depression, chronic pain syndromes, and metabolic health optimization through ketamine infusion protocols, transcranial magnetic stimulation (TMS), and peptide-based weight management therapies. The clinic provides FDA-approved SPRAVATO® (esketamine) nasal spray for patients who meet criteria for treatment-resistant major depressive disorder, alongside traditional IV ketamine infusions administered in a monitored clinical setting. Patients receive treatment in private infusion suites equipped with reclining chairs and comfort amenities designed to support relaxation during sessions that typically last 45 to 60 minutes.
The clinic's peptide therapy program centers on two GLP-1 receptor agonists: semaglutide and tirzepatide, both prescribed for weight management in patients with elevated BMI or obesity-related comorbidities. Semaglutide therapy follows a dose-escalation protocol starting at 0.25 mg weekly, with adjustments based on individual tolerance and metabolic response, while tirzepatide combines GLP-1 and GIP receptor activation for dual-pathway metabolic regulation. These peptide protocols integrate with nutritional counseling and metabolic monitoring to address insulin resistance, appetite dysregulation, and cardiovascular risk factors common in patients seeking sustainable weight reduction. The clinic structures peptide programs as ongoing treatment plans with regular follow-up visits to assess efficacy markers including fasting glucose, hemoglobin A1c, and body composition changes.
Treatment protocols at Southwest Ohio Ketamine TMS and IV Therapy address conditions including major depressive disorder, post-traumatic stress disorder, fibromyalgia, complex regional pain syndrome, and migraine disorders through ketamine's NMDA receptor modulation and neuroplastic effects. TMS therapy utilizes repetitive magnetic pulses targeting the dorsolateral prefrontal cortex, typically delivered in daily sessions over four to six weeks for patients who prefer non-pharmacological intervention or have contraindications to ketamine therapy. The clinic coordinates with referring psychiatrists, pain management specialists, and primary care providers to ensure treatment integration with existing medication regimens and to monitor for potential drug interactions or contraindications.
Patients beginning treatment at the Dayton facility complete comprehensive intake assessments including psychiatric evaluation, medical history review, and contraindication screening before receiving ketamine infusions or initiating peptide therapy. During ketamine sessions, clinical staff monitor vital signs at regular intervals, and patients remain in the clinic for observation following infusion to ensure stability before discharge. The clinic maintains protocols for managing dissociative experiences or blood pressure fluctuations that can occur during ketamine administration, with reversal agents and emergency equipment available on-site. Insurance verification services help patients understand coverage for SPRAVATO® and TMS treatments, though IV ketamine and peptide therapies typically require out-of-pocket payment with options for structured payment plans.
Southwest Ohio Ketamine TMS and IV Therapy serves patients throughout the greater Dayton metropolitan area, including residents of Montgomery County, Greene County, and surrounding communities in southwestern Ohio. The clinic operates on a scheduled appointment basis for all infusion therapies and TMS sessions, with intake coordinators available to answer questions about treatment candidacy, expected timelines, and logistical considerations. Patients receiving ongoing peptide therapy return for monthly follow-up visits that include medication dispensing, side effect assessment, and dose adjustments based on weight loss velocity and tolerance profiles, creating a structured framework for metabolic health management that extends beyond simple medication dispensing.
Topics Mentioned in Reviews
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


